CSPC Pharmaceutical Group Limited in 1 story
The narratives 1093.HK currently appears in, with its side and exposure in each.
Bull side
1 story- China Becomes Pharma's Global R&D Engine
1093.HK in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
CSPC combines a large Chinese commercial base with an innovative pipeline whose antibodies, ADCs and metabolic programs offer multiple opportunities for international licensing.
Bear side
0 storiesNo bear-side stories for 1093.HK yet.